Cardiovascular mortality in end-stage renal disease

被引:211
作者
Collins, AJ [1 ]
机构
[1] Nephrol Analyt Serv, Minneapolis, MN USA
关键词
cardiovascular mortality; end-stage renal disease; chronic kidney disease; coronary artery disease; left ventricular hypertrophy;
D O I
10.1097/00000441-200304000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease accounts for more than 50% of end-stage renal disease (ESRD) deaths. The reported cardiovascular death rates in patients receiving dialysis are substantially higher than in the general population. Cardiovascular mortality in ESRD is particularly high after acute myocardial infarction, but it is also elevated in ESRD patients with other forms of atherosclerotic vascular disease (eg, chronic coronary artery disease, strokes, transient ischemic attacks, and peripheral arterial disease). Left ventricular hypertrophy and dilation are associated with increased cardiovascular mortality, as is congestive heart failure. One of the major reasons for such high cardiovascular mortality in ESRD is the large burden of cardiovascular disease present in patients with chronic artery disease before renal replacement therapy. These observations mandate not only aggressive diagnosis and treatment of cardiovascular disease in patients with ESRD, but also active screening, diagnosis, and treatment in those with chronic kidney disease before renal replacement therapy.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 20 条
[1]  
Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[4]  
Culleton B F, 1998, J Am Soc Nephrol, V9, pS5
[5]   Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency [J].
Culleton, BF ;
Larson, MG ;
Wilson, PWF ;
Evans, JC ;
Parfrey, PS ;
Levy, D .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2214-2219
[6]   Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population [J].
Eggers, PW ;
Gohdes, D ;
Pugh, J .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1524-1533
[7]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[8]   CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGE RENAL-DISEASE THERAPY [J].
FOLEY, RN ;
PARFREY, PS ;
HARNETT, JD ;
KENT, GM ;
MARTIN, CJ ;
MURRAY, DC ;
BARRE, PE .
KIDNEY INTERNATIONAL, 1995, 47 (01) :186-192
[9]   Poor long-term survival after acute myocardial infarction among patients on long-term dialysis [J].
Herzog, CA ;
Ma, JZ ;
Collins, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :799-805
[10]   Long-term survival of dialysis patients in the United States with prosthetic heart valves - Should ACC/AHA practice guidelines on valve selection be modified? [J].
Herzog, CA ;
Ma, JZ ;
Collins, AJ .
CIRCULATION, 2002, 105 (11) :1336-1341